UCB reported EUR56.39B in Market Capitalization this November of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Alcon AG USD 30.94B 4.85B Nov/2026
Almirall EUR 2.28B 168.06M Nov/2026
Amarin USD 290M 51M Dec/2025
argenx SE USD 60.01B 2.38B Sep/2026
AstraZeneca USD 213.88B 23.43B Nov/2026
Bayer EUR 52.42B 5.31B Nov/2026
Genmab DKK 17.1B 88.06B Jun/2026
GlaxoSmithKline GBP 74.11B 6.03B Sep/2026
GRIFOLS EUR 4.76B 1.02B Nov/2026
Hikma Pharmaceutical USD 4.63B 1.42B Dec/2025
Lakefront Biotherapeutics EUR 2.07B 333.44M Nov/2026
Lonza CHF 39.68B 980.61M Jun/2025
Merck EUR 64.74B 46.89B Nov/2026
Novartis USD 292.09B 51.5B Sep/2026
Recordati EUR 10.93B 82.06M Nov/2026
Roche Holding CHF 270B 3.66B Jun/2026
Sanofi EUR 100.56B 13.53B Nov/2026
UCB EUR 46.41B 13.94B Dec/2025
Unibail Rodamco EUR 13.3B 1.68B Dec/2025